Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet’s Gilead Sciences GILD Stock Holding History

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,476	Closed	-$783K	–	65
2020 Q1	$783K	Hold	10,476	–	–	0.58%	49
2019 Q4	$681K	Hold	10,476	–	–	0.44%	57
2019 Q3	$681	Hold	10,476	–	–	0.29%	55
2019 Q2	$681K	Hold	10,476	–	–	0.52%	50
2019 Q1	$681K	Buy	+10,476	New	+$696K	0.61%	43
2018 Q4	–	Sell	-10,476	Closed	-$769K	–	54
2018 Q3	$769K	Hold	10,476	–	–	0.69%	34
2018 Q2	$828K	Hold	10,476	–	–	0.8%	26
2018 Q1	$773K	Buy	10,476 +4,709	+82%	+$374K	0.77%	25
2017 Q4	$413K	Buy	+5,767	New	+$438K	0.47%	23

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's GILD Position: Q2 2020 in Review

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 10,476 shares — an estimated $783K sold.

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet first reported a position in GILD in Q4 2017 and held it in 9 quarters. The position peaked at $828K in Q2 2018. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet sold 10,476 Gilead Sciences shares in Q2 2020, an estimated $783K.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet first reported a position in Gilead Sciences in Q4 2017 and held it in 9 quarters.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's Gilead Sciences position peaked at $828K in Q2 2018.
1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's 13F filing for Q2 2020, filed 28 Jul 2020.